Relevancia fisiopatológica del tamaño hepático en la cirrosis experimental
Loading...
Download
Official URL
Full text at PDC
Publication date
2024
Defense date
25/04/2023
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citation
Abstract
La enfermedad hepática crónica es uno de los principales problemas de salud a nivel mundial por su enorme incidencia y gravedad. La caracterización y el estadiaje de la enfermedad hepática crónica es uno de los principales retos en la práctica clínica, siendo fundamental para el manejo y tratamiento de estos pacientes. En este contexto, es bien conocido que el hígado experimenta cambios de tamaño a lo largo de la historia natural de la enfermedad, consistiendo característicamente en un agrandamiento inicial (hepatomegalia) seguido de una atrofia progresiva. El tamaño del hígado y los cambios que experimenta, por tanto, podrían ayudar a determinar el estadio de la enfermedad hepática crónica. La hipótesis del presente trabajo fue que la disminución de tamaño o atrofia del hígado representa un hito crucial en la historia natural de la enfermedad hepática crónica que se asocia a cambios fundamentales en el perfil clínico, analítico, pronóstico, de expresión génica hepática y extra-hepática, y de la microbiota intestinal...
Chronic liver disease is one of the leading health problems worldwide due to its enormous incidence and severity. The characterization and staging of chronic liver disease is one of the main challenges of clinical practice, being fundamental for managing and treating these patients. In this context, it is well known that the liver undergoes changes in size throughout the natural history of the disease, characteristically consisting of an initial enlargement (hepatomegaly) followed by progressive atrophy. The size of the liver and the changes it undergoes, therefore, could help determine the stage of chronic liver disease.The hypothesis of the present work was that the decrease in liver size, or hepatic atrophy, represents a crucial milestone in the natural history of chronic liver disease that is associated with fundamental changes in the clinical, analytical, prognostic, hepatic and extra-hepatic gene expression, and gut microbiota profile...
Chronic liver disease is one of the leading health problems worldwide due to its enormous incidence and severity. The characterization and staging of chronic liver disease is one of the main challenges of clinical practice, being fundamental for managing and treating these patients. In this context, it is well known that the liver undergoes changes in size throughout the natural history of the disease, characteristically consisting of an initial enlargement (hepatomegaly) followed by progressive atrophy. The size of the liver and the changes it undergoes, therefore, could help determine the stage of chronic liver disease.The hypothesis of the present work was that the decrease in liver size, or hepatic atrophy, represents a crucial milestone in the natural history of chronic liver disease that is associated with fundamental changes in the clinical, analytical, prognostic, hepatic and extra-hepatic gene expression, and gut microbiota profile...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Medicina, leída el 25-04-2023